Absence of toxicity associated with adenoviral-mediated transfer of the β-galactosidase reporter gene to neonatal rat islets in vitro

Diabetes Research and Clinical Practice

Volumn 44, Issue 3, 1999, Pages 157-163

  O'Brien, Timothy ^a   Karlsen, Allan E ^b   Andersen, Henrik U ^b   Mandrup Poulsen, Thomas ^b   Nerup, Jørn ^b  

^a MAYO CLINIC   (United States)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

Adenovirus; Gene therapy; Gene transfer; Islets of Langerhans

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; GENETIC STABILITY; INSULIN RELEASE; NEWBORN; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PROTEIN EXPRESSION; RAT;

ADENOVIRUSES, HUMAN; ANIMALS; BETA-GALACTOSIDASE; CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GLUCOSE; INSULIN; INSULINOMA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREATIC NEOPLASMS; RATS; RATS, WISTAR; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0033036089     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00032-7     Document Type: Article

References (21)

1. Ricordi C., Tzakis A., Carroll P. et al. Human islet allotransplantation in 18 diabetic patients. Transplant. Proc. 24:1992;961.
2. Bosi E., Bottazzo G.F., Secchi A. et al. Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation. Diabetes. 38:1989;82.
3. Hullett D.A. Gene therapy in transplantation. J Heart Lung Transplant. 15:1996;857-862.
4. Saldeen J., Curiel D.T., Eizirik D.L. et al. Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes. 45:1996;1197-1203.
5. Wilson J.M. Adenoviruses as gene-delivery vehicles. New Engl. J. Med. 334:1996;1185-1187.
6. Becker T.C., BeltrandelRio H., Noel R.T., Johnson J.H., Newgard C.B. Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. J. Biol. Chem. 269:1994;21234-21238.
7. Csete M.E., Benhamou P.Y., Drazan K.E. et al. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation. 59:1995;263-268.
8. Korbutt G.S., Smith D.K., Rajotte R.V., Elliott J.F. Expression of β-galactosidase in mouse pancreatic islets by adenoviral-mediated gene transfer. Transplant. Proc. 27:1995;3414.
9. Sigalla J., David A., Anegon I. et al. Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: normal p-cell function despite induction of an anti adenovirus immune response. Human Gene Ther. 8:1997;1625-1634.
10. Yang Y., Nunes F.A., Berencsi K., Furth E.E., Gonczol E., Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:1994;4407-4411.
11. Yang Y., Li Q., Ertl H.C.J., Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
12. Engelhardt J.F., Ye X., Doranz B., Wilson J.M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA. 91:1994;6196-6200.
13. Quinones M.J., Leor J., Kloner R.A. et al. Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus. Circulation. 94:1996;1394-1401.
14. Kay M.A., Holterman A.X., Meuse L. et al. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA41g administration. Nat. Genet. 11:1995;191-197.
15. Fang B., Eisensmith R.C., Wang H. et al. Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Human Gene Ther. 6:1995;1039-1044.
16. Jooss K., Yang Y., Wilson J.M. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Human Gene Ther. 7:1996;1555-1566.
17. Yap J., O'Brien T., Tazelaar H.D., McGregor C.G.A. Immunosuppression prolongs adenoviral mediated transgene expression in cardiac allograft transplantation. Cardiovasc. Res. 35:1997;529-535.
18. Chen H.H., Mack L.M., Kelly R., Ontell M., Kochanek S., Clemens P.R. Persistence in muscle of adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. USA. 94:1997;1645-1650.
19. Kochanek S., Clemens P.R., Mitani K., Chen H.H., Chan S., Caskey C.T. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA. 93:1996;5731-5736.
20. Newman K.D., Dunn P.F., Owens J.W., Schulick A.H., Virmani R., Sukhova G., Libby P., Dichek D.A. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J. Clin. Invest. 96:1995;2955-2965.
21. Herz J., Gerard R.D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA. 90:1993;2812-2816.